Thyrocare Technologies Limited (THYROCARE.BO)
INR 895.35
(2.05%)
INR 895.35
(2.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 917 Million INR | 4.47% |
| 2022 | 865.5 Million INR | -57.66% |
| 2021 | 2.04 Billion INR | 40.41% |
| 2020 | 1.45 Billion INR | -0.11% |
| 2019 | 1.45 Billion INR | 12.91% |
| 2018 | 1.29 Billion INR | 0.86% |
| 2017 | 1.27 Billion INR | 28.12% |
| 2016 | 998.98 Million INR | 44.14% |
| 2015 | 693.05 Million INR | 12.63% |
| 2014 | 615.34 Million INR | -1.66% |
| 2013 | 625.7 Million INR | 4.03% |
| 2012 | 601.49 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 352.2 Million INR | 12.6% |
| 2024 Q1 | 312.8 Million INR | 50.75% |
| 2023 Q1 | 246.8 Million INR | 77.68% |
| 2023 Q4 | 207.5 Million INR | 14.51% |
| 2023 FY | 904.2 Million INR | 4.47% |
| 2023 Q3 | 181.2 Million INR | -32.56% |
| 2023 Q2 | 268.7 Million INR | 8.87% |
| 2022 Q4 | 138.9 Million INR | -21.57% |
| 2022 Q1 | 273.1 Million INR | -2.18% |
| 2022 FY | 865.5 Million INR | -57.66% |
| 2022 Q3 | 177.1 Million INR | -21.04% |
| 2022 Q2 | 224.3 Million INR | -17.87% |
| 2021 Q2 | 811.3 Million INR | 26.88% |
| 2021 Q3 | 280 Million INR | -65.49% |
| 2021 FY | 2.04 Billion INR | 40.41% |
| 2021 Q4 | 279.2 Million INR | -0.29% |
| 2021 Q1 | 639.4 Million INR | 69.29% |
| 2020 Q2 | 592 Million INR | 2316.33% |
| 2020 FY | 1.45 Billion INR | -0.11% |
| 2020 Q4 | 377.7 Million INR | -14.97% |
| 2020 Q1 | 24.5 Million INR | -87.56% |
| 2020 Q3 | 444.2 Million INR | -24.97% |
| 2019 Q1 | 408 Million INR | 68.18% |
| 2019 Q2 | 466.6 Million INR | 14.36% |
| 2019 Q3 | 368.7 Million INR | -20.98% |
| 2019 Q4 | 197 Million INR | -46.57% |
| 2019 FY | 1.45 Billion INR | 12.91% |
| 2018 Q2 | 392.7 Million INR | 4.05% |
| 2018 FY | 1.29 Billion INR | 0.86% |
| 2018 Q4 | 242.6 Million INR | -24.52% |
| 2018 Q3 | 321.4 Million INR | -18.16% |
| 2018 Q1 | 377.4 Million INR | -11.18% |
| 2017 Q4 | 424.92 Million INR | 25.31% |
| 2017 Q2 | 344.4 Million INR | -6.34% |
| 2017 Q3 | 339.1 Million INR | -1.54% |
| 2017 Q1 | 367.7 Million INR | 27.48% |
| 2017 FY | 1.27 Billion INR | 28.12% |
| 2016 Q1 | 258.9 Million INR | 44.78% |
| 2016 FY | 998.98 Million INR | 44.14% |
| 2016 Q2 | 456.47 Million INR | 76.31% |
| 2016 Q3 | 323.93 Million INR | -29.04% |
| 2016 Q4 | 288.43 Million INR | -10.96% |
| 2015 Q1 | 166.54 Million INR | 0.0% |
| 2015 Q2 | 248.81 Million INR | 49.4% |
| 2015 Q4 | 178.82 Million INR | -3.05% |
| 2015 Q3 | 184.45 Million INR | -25.87% |
| 2015 FY | 693.05 Million INR | 12.63% |
| 2014 FY | 615.34 Million INR | -1.66% |
| 2013 FY | 625.7 Million INR | 4.03% |
| 2012 FY | 601.49 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 696.99 Million INR | -31.566% |
| Dr. Lal PathLabs Limited | 4.76 Billion INR | 80.746% |
| Metropolis Healthcare Limited | 2.05 Billion INR | 55.385% |
| Vijaya Diagnostic Centre Limited | 3.62 Billion INR | 74.728% |
| Vimta Labs Limited | 536.04 Million INR | -71.066% |